DUBLIN, March 1, 2024 /PRNewswire/ — The “Asia-Pacific Artificial Intelligence/ Machine Learning Medical Device Market: Analysis and Forecast, 2022-2032” report has been added to ResearchAndMarkets.com’s offering.
The Asia-Pacific artificial intelligence/machine learning medical device market was valued at $681.9 million in 2022 and is anticipated to reach $6,800.9 million by 2032, witnessing a CAGR of 25.86% during the forecast period 2022-2032
The market experiences growth due to factors including a substantial ecosystem of companies providing AI solutions, increasing demand in radiology and cardiology, a rising need for wearable sensors, and numerous government initiatives.
Market Introduction
The Asia-Pacific (APAC) Artificial Intelligence and Machine Learning (AI/ML) medical device market is witnessing a significant surge in growth and innovation. This dynamic region is becoming a focal point for the development and adoption of AI and ML technologies in the healthcare sector.
The increasing prevalence of chronic diseases, coupled with a rapidly aging population, is driving the demand for advanced medical devices powered by AI and ML.
These technologies enhance diagnostic accuracy, treatment planning, and patient care, making healthcare more efficient and accessible. Countries in the APAC region are actively investing in healthcare infrastructure and research, fostering a favorable environment for AI/ML medical devices. Moreover, the presence of a vast and diverse patient population provides a unique opportunity for data-driven healthcare solutions.
As the APAC AI/ML medical device market continues to expand, collaborations between technology companies and healthcare providers are on the rise, facilitating the development of cutting-edge medical devices and driving improvements in patient outcomes.
How can this report add value to an organization?
Growth/Marketing Strategy: The APAC artificial intelligence/machine learning medical device market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint ventures. Partnerships, alliances, business expansions, and regulatory activities accounted for the maximum number of key developments.
Competitive Strategy: The APAC artificial intelligence/machine learning medical device market is highly fragmented, including established companies and startups. Key players in the APAC artificial intelligence/machine learning medical device market analyzed and profiled in the study involve established and emerging players that offer different AI-enabled medical devices. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Key Market Players
- Canon Inc.
- Shanghai United Imaging Healthcare Co., Ltd.
- Ever Fortune.AI Co., Ltd.
- MedMind Technology Co., Ltd.
- AIRS Medical Inc.
- Annalise-AI
Key Topics Covered:
Executive Summary
Scope of the Study
Research Methodology
1 Markets
1.1 Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.1.3 Key Findings
1.1.4 Market Scenario
1.1.4.1 Realistic Growth Scenario
1.1.4.2 Optimistic Growth Scenario
1.1.4.3 Pessimistic/Conservative Growth Scenario
1.2 Industry Outlook
1.2.1 Market Overview
1.2.2 Key Trends
1.2.2.1 Updations of Government Regulations to Accommodate the Development and Regulation of AI-enabled SaMD
1.2.2.2 Most AI-Enabled Medical Devices Aid in Clinical Decision-Making but do not Provide the Final Diagnosis Themselves
1.2.2.3 Very Few AI-Enabled Medical Devices Have to Undergo the Rigorous PMA Process: Rest Get 510(k) Clearance
1.2.3 Opportunity Assessment
1.2.4 Business Models
1.2.5 Recommendations for Key Players
1.2.6 Patent Analysis
1.2.6.1 Awaited Technological Developments
1.2.6.2 Patent Filing Trend (by Country)
1.2.6.3 Patent Filing Trend (by Year)
1.2.7 Funding Scenario
1.2.8 Product Benchmarking
1.2.9 End User Perception
1.3 Impact of COVID-19 on the Artificial Intelligence/Machine Learning Medical Device
1.3.1 Pre-COVID-19 Phase
1.3.2 During COVID-19
1.3.2.1 Impact of COVID-19 on Clinical Settings and Clinical Decision-Making
1.3.3 Post-COVID-19 Phase
1.4 Business Dynamics
1.4.1 Impact Analysis
1.4.2 Business Drivers
1.4.2.1 Presence of a Large Ecosystem of Companies Offering AI Solutions Targeting the Diverse Range of Applications of AI in the Healthcare
1.4.2.2 Growing Demand in the Field of Radiology and Cardiology Increasing Adoption of AI-Enabled Solutions due to Their Ability to Shorten Waiting Times and Reduce Burden on Healthcare System
1.4.2.3 Growing Demand for Wearable Sensors to Increase Adoption of AI-Enabled Medical Devices for Home-Based Care
1.4.2.4 Large Number of Government Initiatives Advancing the Research…
Read More: Potential of AI to Shorten Wait Times and Reduce Disease Burden Driving